Product Specification

I. Uses

• Treating Systemic Infections Caused by Susceptible Bacteria: For systemic multi-system infections in pets (such as dogs and cats) caused by susceptible Gram-negative bacteria (e.g., Escherichia coli, Pasteurella), Gram-positive bacteria (e.g., Staphylococcus), and mycoplasma. These infections include respiratory tract infections (such as bacterial bronchitis and pneumonia, which relieve symptoms like coughing and difficulty breathing in pets), urinary system infections (such as bacterial cystitis and urethritis, which improve issues like frequent urination, painful urination, and cloudy urine), and skin and soft tissue infections (such as bacterial dermatitis and abscesses, which promote the healing of infected wounds).
• Addressing Gastrointestinal Infections: Used to treat bacterial enteritis in pets caused by susceptible bacteria, relieving symptoms such as diarrhea, vomiting, and loss of appetite. It reduces the number of pathogenic bacteria in the intestines, helps restore the normal digestive function of the intestines, and is especially suitable for secondary bacterial infections caused by unhygienic diet or environmental stress.
• Assisting in the Treatment of Local Infections: For local susceptible bacterial infections in pets, such as eye infections (e.g., bacterial conjunctivitis) and ear infections (e.g., bacterial otitis media), under the guidance of a veterinarian, the tablets can be crushed and used locally with appropriate excipients (or taken orally as directed by a veterinarian to act on the local area through blood circulation) to help control the spread of infection.

II. Selling Points

• Broad-Spectrum Antibacterial Activity, Wide Application Range: As a fluoroquinolone antibacterial drug, it has a strong inhibitory effect on common Gram-negative bacteria, Gram-positive bacteria, and mycoplasma in pets. It can initially address a variety of bacterial infections without frequent testing of pathogenic bacteria types, making it particularly suitable for rapid intervention during the acute infection period of pets.
• Pet-Specific, Safe and Adaptable: Different from human fluoroquinolone drugs, enrofloxacin tablets for pets comply with the metabolic characteristics of pets (such as dogs and cats) in terms of ingredient dosage and excipient selection. It avoids toxic and side effects caused by improper dosage (e.g., the risk of cartilage damage is controllable at the appropriate dosage) and has passed veterinary medication safety verification, with stronger compliance.
• Tablet Dosage Form, Convenient Administration: Adopting a tablet design, it can be fed directly or crushed and mixed into pet food, canned food, minced meat, and other foods, solving the problem of pets refusing medication. At the same time, the tablets are easy to store and carry, suitable for administration according to the treatment course at home or when going out, with a low operation threshold for pet owners.
• Rapid Onset of Action, Controllable Treatment Course: It is well absorbed after oral administration and can quickly reach the infection site through blood circulation to exert antibacterial effects. Symptoms of most acute infections can be relieved 1-2 days after medication. Moreover, administering medication according to the treatment course recommended by a veterinarian (usually 5-7 days) can effectively reduce the risk of drug resistance and achieve a more stable therapeutic effect.

Enrofloxacin Tablets

25mg x 8 tablets/box x 223 boxes/carton